Literature DB >> 21147929

Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.

M Scott Killian1, Carl Johnson, Fernando Teque, Sue Fujimura, Jay A Levy.   

Abstract

HIV replication is suppressed in vitro by a CD8(+) cell noncytotoxic antiviral response (CNAR). This activity directly correlates with an asymptomatic clinical state. The objective of this study was to identify the phenotype of CD8(+) cell subsets having strong CNAR activity. CD8(+) cell subset frequencies and CNAR levels were measured for human immunodeficiency virus (HIV)-uninfected individuals and three groups of HIV type 1 (HIV-1)-infected individuals: asymptomatic individuals with low-level viremia (vHIV), antiretroviral-drug-treated subjects with undetectable virus levels (TxHIV), and therapy-naïve aviremic elite controllers (EC). CD8(+) cells from the vHIV individuals exhibited the highest HIV-suppressing activity and had elevated frequencies of CD45RA(-) CD27(+) and PD-1(+) (CD279(+)) cells. Functional assessments of CD8(+) cells sorted into distinct subsets established that maximal CNAR activity was mediated by CD45RA(-) CCR7(-) CD27(+) and PD-1(+) CD8(+) cells. T cell receptor (TCR) repertoire profiles of CD8(+) cell subsets having strong CNAR activity exhibited increased perturbations in comparison to those of inactive subsets. Together, these studies suggest that CNAR is driven by HIV replication and that this antiviral activity is associated with oligoclonally expanded activated CD8(+) cells expressing PD-1 and having a transitional memory cell phenotype. The findings better describe the identity of CD8(+) cells showing CNAR and should facilitate the evaluation of this important immune response in studies of HIV pathogenesis, resistance to infection, and vaccine development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147929      PMCID: PMC3028886          DOI: 10.1128/JVI.01120-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  A screening assay for detecting CD8+ cell non-cytotoxic anti-HIV responses.

Authors:  M Scott Killian; Sharon Ng; Carl E Mackewicz; Jay A Levy
Journal:  J Immunol Methods       Date:  2005-09       Impact factor: 2.303

2.  Clonal breadth of the HIV-1-specific T-cell receptor repertoire in vivo as determined by subtractive analysis.

Authors:  M Scott Killian; Rachel Lubong Sabado; Stephanie Kilpatrick; Mary Ann Hausner; Beth D Jamieson; Otto O Yang
Journal:  AIDS       Date:  2005-06-10       Impact factor: 4.177

Review 3.  The PD-1-PD-L pathway in immunological tolerance.

Authors:  Taku Okazaki; Tasuku Honjo
Journal:  Trends Immunol       Date:  2006-02-24       Impact factor: 16.687

4.  CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children.

Authors:  J A Levy; F Hsueh; D J Blackbourn; D Wara; P S Weintrub
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

5.  VCAM-1 expression on CD8+ cells correlates with enhanced anti-HIV suppressing activity.

Authors:  Leyla S Diaz; Hillary Foster; Mars R Stone; Sue Fujimura; David A Relman; Jay A Levy
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

6.  Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats.

Authors:  D H Gebhard; J L Dow; T A Childers; J I Alvelo; M B Tompkins; W A Tompkins
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

7.  Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome.

Authors:  E Barker; C E Mackewicz; G Reyes-Terán; A Sato; S A Stranford; S H Fujimura; C Christopherson; S Y Chang; J A Levy
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

8.  HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication.

Authors:  C E Mackewicz; M R Garovoy; J A Levy
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals.

Authors:  J E Schmitz; M A Forman; M A Lifton; O Concepción; K A Reimann; C S Crumpacker; J F Daley; R S Gelman; N L Letvin
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

10.  Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.

Authors:  S A Stranford; J Skurnick; D Louria; D Osmond; S Y Chang; J Sninsky; G Ferrari; K Weinhold; C Lindquist; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

View more
  24 in total

1.  Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication.

Authors:  Stephanie A Freel; Ralph A Picking; Guido Ferrari; Haitao Ding; Christina Ochsenbauer; John C Kappes; Jennifer L Kirchherr; Kelly A Soderberg; Kent J Weinhold; Coleen K Cunningham; Thomas N Denny; John A Crump; Myron S Cohen; Andrew J McMichael; Barton F Haynes; Georgia D Tomaras
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

2.  IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques.

Authors:  Rashmi Jalah; Vainav Patel; Viraj Kulkarni; Margherita Rosati; Candido Alicea; Brunda Ganneru; Agneta von Gegerfelt; Wensheng Huang; Yongjun Guan; Kate E Broderick; Niranjan Y Sardesai; Celia LaBranche; David C Montefiori; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

Review 3.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

4.  Analysis of the CD8+ T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.

Authors:  M Scott Killian; Fernando Teque; Ramu Sudhagoni
Journal:  Immunogenetics       Date:  2017-07-22       Impact factor: 2.846

5.  Inhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressors.

Authors:  Robert W Buckheit; Maria Salgado; Robert F Silciano; Joel N Blankson
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

6.  High-level, lasting antiviral immunity induced by a bimodal AIDS vaccine and boosted by live-virus exposure: prevention of viremia.

Authors:  Robert A Rasmussen; Nagadenahalli B Siddappa; Samir K Lakhashe; Jennifer Watkins; François Villinger; Chris Ibegbu; Ruth H Florese; Marjorie Robert-Guroff; David C Montefiori; Donald N Forthal; David O'Connor; Ruth M Ruprecht
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

7.  Large granular lymphocytes are universally increased in human, macaque, and feline lentiviral infection.

Authors:  Wendy S Sprague; Cristian Apetrei; Anne C Avery; Robert L Peskind; Sue Vandewoude
Journal:  Vet Immunol Immunopathol       Date:  2015-07-29       Impact factor: 2.046

8.  Canonical Wnts Mediate CD8+ T Cell Noncytolytic Anti-HIV-1 Activity and Correlate with HIV-1 Clinical Status.

Authors:  Jennillee Wallace; Srinivas D Narasipura; Beverly E Sha; Audrey L French; Lena Al-Harthi
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

9.  Elevated CD8 counts during HAART are associated with HIV virologic treatment failure.

Authors:  Elizabeth M Krantz; Katherine Huppler Hullsiek; Jason F Okulicz; Amy C Weintrob; Brian K Agan; Nancy F Crum-Cianflone; Anuradha Ganesan; Tomas M Ferguson; Braden R Hale
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

Review 10.  CD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesis.

Authors:  Korey R Demers; Morgan A Reuter; Michael R Betts
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.